Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria.
Ochi H, Hiraoka A, Hirooka M, Koizumi Y, Amano M, Azemoto N, Watanabe T, Yoshida O, Tokumoto Y, Mashiba T, Yokota T, Abe M, Michitaka K, Hiasa Y, Joko K.
Ochi H, et al. Among authors: amano m.
J Gastroenterol. 2021 Jan;56(1):90-100. doi: 10.1007/s00535-020-01747-y. Epub 2020 Dec 5.
J Gastroenterol. 2021.
PMID: 33278003
Free PMC article.